Germany· DE-A57-c8a767c67f85c12a
Levendex
A medicinal product containing dexamethasone, levofloxacin, registered in Germany by Ntc Srl.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dexamethasone, Levofloxacin
- Manufacturer
- Ntc Srl
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethasone, levofloxacin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandDucressaDelfarma Sp. z o.o.
- SpainDUCRESSA 1 MG/ML + 5 MG/ML COLIRIO EN SOLUCIONSanten Oy
- United KingdomDucressa 1mg/ml / 5mg/ml eye dropsSanten UK Ltd
- IrelandDucressa 1 mg/ml + 5 mg/ml, eye drops, solutionSanten OY
- IcelandDucressaSanten Oy*
- NetherlandsDucressa 1 mg/ml / 5 mg/ml, oogdruppels, oplossingSanten Oy
- NorwayDucressaSanten Oy (1)
- SwedenDucressa 1 mg/ml + 5 mg/ml Ögondroppar, lösningSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Ducressa
- Bulgaria · Ducressa
- Estonia · Ducressa
- Greece · Ducressa
- Croatia · Ducressa
- Ireland · Ducressa
- Italy · Ducressa, Leviosa
- Lithuania · Ducressa
- Netherlands · Ducressa
- Norway · Ducressa
- Romania · Ducressa Md
- Sweden · Ducressa
- Slovenia · Ducressa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1693db39-e04d-4d07-b783-4c913f2348a7 GET /v1/drugs/1693db39-e04d-4d07-b783-4c913f2348a7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dexamethasone, Levofloxacin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dexamethasone, levofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.